🧵 #ExercisePrescriptions 1/5 The TI’s Dr. Josh Levin asks: Clinicians, can you help your patients be more active? 🏃🏾‍♀️🏊🏾‍♂️ 🚶🏾‍♂️ 👉🏾Watch Dr. Levin’s presentation: youtube.com/watch?v=G5heA-… #Exercise #prescribing #twitterRx

🚨Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/146518… "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

🚨 Revisión sistemática actualizada: Retirada de antihipertensivos en personas mayores 💊 🔍 Se recomienda focalizar futuras investigaciones en poblaciones con mayor incertidumbre sobre beneficio:riegos cochranelibrary.com/cdsr/doi/10.10… #CochraneEvidence #bloodpressure #deprescribing

🚨 TI #BestEvidence webinar: Dr. Josh Levin compares #PhysicalActivity to drugs for important clinical outcomes ti.ubc.ca/drugevidence24 #DrugEvidence24 #exercise #MedEd

ICYMI: #BestEvidence webinar recording Debunking some of the hype in #hypertension ti.ubc.ca/drugevidence24 Dr. Jim Wright summarizes latest evidence on #antihypertensives ⏰ chronotherapy 💊 first line tx 🎯 BP targets ⚠️ tx efficacy + safety #DrugEvidence24 #MedEd #medsafety

ICYMI - Debunking some of the hype in #Hypertension ti.ubc.ca/drugevidence24 Dr. James Wright summarizes latest evidence on #antihypertensives: ⏰ chronotherapy 💊 first line tx 🎯 blood pressure targets ⚠️ tx efficacy + safety #meded #medsafety

🚨Cochrane #SystematicReview 🎺 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/146518… #CochraneEvidence #Blogshot

🆕Our new Cochrane #SystematicReview protocol: Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists doi.org/10.1002/146518…

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/146518… "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/146518… "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

Cochrane Library editorial: Achieving sustainable healthcare through deprescribing cochranelibrary.com/cdsr/doi/10.10…

ICYMI: What happens when invisible/abandoned clinical trials are re-examined? 🔍🤔 Watch Dr. Juan Erviti DTB Navarre Restoring Invisible & Abandoned Trials in our TI #BestEvidence webinar: ti.ubc.ca/RIAT #MedEd #medsafety #SegPac #ResearchMethods

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/146518… "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

🚨ICYMI - Cochrane #SystematicReview Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/146518… #CochraneEvidence #Blogshot

🆕Review update🆕 Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10.10… In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

🆕Review update: Pharmacotherapy for #hypertension in adults 60 years or older cochranelibrary.com/cdsr/doi/10.10… Tx healthy adults 60 yrs+ with moderate-severe HTN with antihypertensives reduced all‐cause mortality & probably reduced cardiovascular mortality/morbidity #SystematicReview

ICYMI - Review update: Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10.10… In people w/ mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview